Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of the Central Nervous System (CNS) and spine. Neurovascular Thrombectomy Devices are used for the removal of a blood clot in the neurovascular vessels during an acute ischemic stroke. GlobalData uses proprietary data and analytics to provide a comprehensive report on the neurovascular thrombectomy devices devices market, including market shares of different players within Switzerland. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the neurovascular thrombectomy devices market in Switzerland was Medtronic followed by Stryker, Cerenovus, Penumbra, MicroVention, Rapid Medical, Balt and Acandis.
The two types of devices are Stent Retrievers and Aspiration Catheters. Stent Retrievers are deployed by a catheter that is threaded through the clot. An Aspiration Catheter is a micro-vacuum that is fed into affected vessels to remove large vessel occlusions during an acute ischemic stroke.
The value of the neurovascular thrombectomy devices devices market within Switzerland was expected to be over $10m in 2023.
For the latest complete market share analysis of neurovascular thrombectomy devices device market in Switzerland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
